U-M researchers seek answers for African-Americans at risk for prostate cancer

Community-based study samples Flint, Mich., population of black men

ANN ARBOR, Mich. Doctors know that black men face a much higher risk of prostate cancer than whites, and a higher risk of dying from the disease. And while research is zeroing in on answers, too few African-American men have ever been involved enough to determine if a promising genetic finding applied to African-American as well as Caucasian men.

Now, a new study by University of Michigan Health System researchers found that the gene, macrophage scavenger receptor 1, or MSR1, does indeed play a role in prostate cancer in African-American men. The study, which will be published in the July 1 issue of the American Association for Cancer Research's journal Cancer Research, came from a larger project called the Flint Men's Health Study, aimed at identifying risk factors for prostate cancer in African-American men. It is a rare effort to recruit large numbers of African-Americans in a population-based research study.

"African-American men have the highest incidence of prostate cancer in the world. The severity is higher and they tend to die more quickly after diagnosis," says Kathleen Cooney, M.D., associate professor of Internal Medicine and Surgery at the U-M Comprehensive Cancer Center and senior author of the study. "We don't know why this is, but part of the difficulty is that African-American men are underrepresented in most genetics studies."

In this particular study, researchers looked at African-American men ages 40-79 who live in Flint, Mich. Researchers compared DNA samples from 134 African-American men diagnosed with prostate cancer with samples from 340 African-American men without prostate cancer. Five common variants and five recently reported mutations were analyzed. Researchers determined that rare germ-line MSR1 mutations were associated with an increased prostate cancer risk.

The findings echo previous studies' results that sho

Contact: Nicole Fawcett
University of Michigan Health System

Page: 1 2 3 4

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:

(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... , ... August 11, 2020 , ... ... based in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI ... Both Roche and J&J have annual Research and Development spending in excess ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted ... will cover the history of eSource, the reasons it did not take off as ... to site source, the industry is moving towards capturing data electronically for clinical trials ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign ... detection and prevention of high-burden diseases, and Centric Consulting, a business and technology ... to utilize existing data in order to identify and prioritize patients for care. ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
Breaking Biology Technology:
Cached News: